Sepsis

Overview

Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. It represents one of the most significant and preventable causes of morbidity and mortality worldwide, affecting an estimated 48.9 million people annually and claiming approximately 11 million lives — nearly 20% of all global deaths (Rudd et al., 2020). In the United States alone, sepsis is responsible for more than 1.7 million hospitalizations per year, making it the leading cause of death in non-coronary intensive care units and accounting for up to one-third of all in-hospital deaths.

The Sepsis-3 international consensus definitions, published in 2016, redefined sepsis as organ dysfunction resulting from a dysregulated host response to infection, replacing the older systemic inflammatory response syndrome (SIRS)-based criteria. This shift reflected growing recognition that sepsis is not simply an exaggerated inflammatory response but a complex syndrome involving simultaneous pro-inflammatory and anti-inflammatory dysregulation, endothelial injury, coagulopathy, and metabolic failure at the cellular level. Septic shock — the most severe subset — is defined as sepsis with circulatory and cellular/metabolic abnormalities that substantially increase mortality risk, characterized clinically by persistent hypotension requiring vasopressors to maintain a mean arterial pressure (MAP) ≥ 65 mmHg and a serum lactate > 2 mmol/L despite adequate fluid resuscitation.

For the BSN-prepared nurse, sepsis demands mastery of rapid recognition, early goal-directed assessment, timely intervention, and seamless interprofessional collaboration. The nurse is typically the first provider to identify the constellation of early warning signs that precede overt hemodynamic collapse. Delays of even one hour in antibiotic administration or fluid resuscitation are independently associated with increased mortality. Understanding sepsis pathophysiology, clinical presentation, and the evidence-based Hour-1 Bundle is therefore an essential component of nursing practice across all care settings — from the emergency department and medical-surgical unit to the intensive care unit and post-acute environment.

---

Pathophysiology

Initiating Event: Infection and Microbial Pattern Recognition

Sepsis begins with a localized or systemic infection caused by bacteria (gram-positive or gram-negative), fungi, viruses, or parasites. The host immune system detects pathogen-associated molecular patterns (PAMPs) — such as lipopolysaccharide (LPS) from gram-negative bacterial cell walls, peptidoglycan from gram-positive organisms, or viral RNA — through pattern recognition receptors (PRRs), most notably Toll-like receptors (TLRs) on immune effector cells, including macrophages, monocytes, neutrophils, and dendritic cells.

Receptor activation triggers intracellular signaling cascades — principally through nuclear factor-kappa B (NF-κB) — that result in the massive transcription and release of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), and interferon-gamma (IFN-γ). Under normal circumstances, these mediators orchestrate the recruitment of immune effector cells to the site of infection, enhancing pathogen clearance. In sepsis, this response becomes systemic, uncontrolled, and self-perpetuating.

Endothelial Dysfunction and Vascular Leak

The vascular endothelium is a primary target of sepsis-related injury. Circulating pro-inflammatory cytokines — particularly TNF-α and IL-1β — activate endothelial cells, causing upregulation of adhesion molecules (e.g., E-selectin, ICAM-1, VCAM-1), increased vascular permeability, loss of the glycocalyx layer, and the interstitial shift of protein-rich fluid. The resulting capillary leak syndrome is responsible for the characteristic third-spacing of fluid seen in sepsis: relative hypovolemia despite total body fluid excess, interstitial edema, pulmonary edema, and impaired oxygen delivery to tissues.

Endothelial nitric oxide synthase (eNOS) is also activated by cytokine stimulation, producing excess nitric oxide (NO). While NO serves critical physiological roles in vascular tone regulation, excessive NO production in sepsis causes profound arteriolar vasodilation, reduced systemic vascular resistance (SVR), distributive hypotension, and loss of the normal vasoconstrictive response to catecholamines — the hemodynamic hallmark of septic shock.

Coagulation Dysregulation: Sepsis-Induced Coagulopathy

Endothelial injury and inflammatory mediator release activate the coagulation cascade while simultaneously suppressing natural anticoagulant pathways. Tissue factor expressed on activated monocytes and endothelial cells initiates the extrinsic coagulation cascade. Simultaneously, protein C, antithrombin III, and tissue factor pathway inhibitor (TFPI) — the principal natural anticoagulants — are depleted. The result is a procoagulant state characterized by widespread microvascular thrombus formation, fibrin deposition, and microangiopathy that compromises capillary perfusion in multiple organ systems.

As the process continues, consumption of clotting factors and platelets may exhaust the body’s hemostatic reserves, progressing to disseminated intravascular coagulation (DIC) — a devastating syndrome of simultaneous thrombosis and hemorrhage that dramatically worsens organ failure and mortality.

Mitochondrial Dysfunction and Cytopathic Hypoxia

A paradox of advanced sepsis is that oxygen delivery to tissues may be compromised even when measured tissue oxygenation parameters appear adequate. The mechanism is cytopathic hypoxia: mitochondrial dysfunction induced by reactive oxygen species (ROS), excess NO, and inflammatory mediators impairs cellular ability to utilize oxygen for aerobic respiration, regardless of supply. Cells are forced into anaerobic glycolysis, producing lactate even in the absence of tissue hypoperfusion. Elevated serum lactate in sepsis therefore reflects both inadequate oxygen delivery (distributive) and impaired cellular oxygen utilization — a distinction with important clinical implications.

Immunosuppression and the Anti-Inflammatory Counter-Response

While the initial phase of sepsis is dominated by hyperinflammation, the body rapidly mounts a compensatory anti-inflammatory response syndrome (CARS) in an attempt to limit tissue damage. In patients who survive the initial inflammatory surge, CARS may persist and lead to profound immunosuppression: lymphocyte apoptosis, T-cell exhaustion, monocyte deactivation, and impaired neutrophil function. This immunoparalysis phase leaves patients highly susceptible to secondary infections — particularly with opportunistic and nosocomial pathogens — and is a major driver of late sepsis mortality.

Organ Failure: The Common Final Pathway

The combined effects of endothelial dysfunction, microvascular coagulopathy, distributive hypotension, cytopathic hypoxia, and immunosuppression converge on individual organs to produce the multiorgan dysfunction syndrome (MODS) that defines severe sepsis and septic shock. Commonly affected organs and systems include:

• Lungs: Acute respiratory distress syndrome (ARDS) secondary to capillary leak, surfactant depletion, and alveolar flooding — the most common organ failure in sepsis
• Kidneys: Acute kidney injury (AKI) from renal hypoperfusion, endothelial injury, and tubular cell apoptosis
• Cardiovascular system: Septic cardiomyopathy with biventricular dysfunction, reduced ejection fraction, and ventricular dilation — potentially reversible with treatment
• Liver: Cholestatic injury, reduced synthetic function, coagulopathy
• Brain: Sepsis-associated encephalopathy (SAE) ranging from confusion and delirium to coma
• Gastrointestinal tract: Ileus, mucosal barrier disruption, translocation of gut bacteria, stress ulceration

---

Clinical Presentation / Signs and Symptoms

The clinical presentation of sepsis is highly variable and depends on the source of infection, the causative organism, the patient’s baseline immune status, and the stage of the syndrome at the time of presentation. A high index of clinical suspicion is essential, as early sepsis may mimic a range of less urgent conditions.

Sepsis-3 Diagnostic Criteria

The Sepsis-3 definitions provide the contemporary framework for diagnosis:

• Sepsis: Suspected or confirmed infection plus an acute increase in the Sequential Organ Failure Assessment (SOFA) score of ≥ 2 points from baseline, representing life-threatening organ dysfunction.
• Septic Shock: Sepsis with the need for vasopressors to maintain MAP ≥ 65 mmHg AND serum lactate > 2 mmol/L (18 mg/dL) despite adequate volume resuscitation.

qSOFA: A Bedside Screening Tool

The quick SOFA (qSOFA) tool provides a rapid, validated bedside screen for patients with suspected infection who may be at risk for sepsis. It does not replace the full SOFA score but is useful in non-ICU settings for triggering further evaluation. A score of ≥ 2 warrants urgent reassessment:

qSOFA Criterion	Score
Respiratory rate ≥ 22 breaths/min	1
Altered mental status (GCS < 15)	1
Systolic blood pressure ≤ 100 mmHg	1

Common Signs and Symptoms

Early sepsis may present with subtle, non-specific findings that require vigilant nursing assessment:

Vital sign abnormalities:

• Fever (temperature > 38.3°C / 100.9°F) or hypothermia (< 36°C / 96.8°F) — hypothermia is a particularly ominous sign in the elderly and immunocompromised
• Tachycardia (heart rate > 90 beats/min)
• Tachypnea (respiratory rate > 20 breaths/min)
• Hypotension (systolic BP < 90 mmHg, MAP < 65 mmHg, or ≥ 40 mmHg decrease from baseline) — may be absent in early sepsis

Neurological:

• Altered mental status, confusion, agitation, lethargy, or frank encephalopathy — often the earliest sign in older adults

Respiratory:

• Increased work of breathing, accessory muscle use, hypoxemia (SpO₂ < 94%)

Cardiovascular:

• Bounding or thready peripheral pulses (depending on stage), prolonged capillary refill > 2 seconds, mottled or clammy skin

Renal:

• Decreased urinary output (< 0.5 mL/kg/hr for ≥ 2 hours)

Integumentary:

• Flushed, warm, diaphoretic skin (early hyperdynamic phase); cool, mottled, pale or cyanotic extremities (late/decompensating phase)
• Petechiae or purpura — suggests coagulopathy or specific organisms (e.g., Neisseria meningitidis)

Gastrointestinal:

• Nausea, vomiting, abdominal pain or tenderness, ileus, absent bowel sounds

---

Diagnostic Studies and Laboratory Findings

No single laboratory test confirms or excludes sepsis. Diagnosis relies on clinical context — known or suspected infection combined with evidence of acute organ dysfunction. The following studies are routinely obtained to establish the diagnosis, identify the source of infection, assess organ function, and guide resuscitation.

Microbiological Studies

• Blood cultures (× 2 sets from separate sites): Obtained before antibiotic administration whenever possible; positive in approximately 30–40% of sepsis cases. Each set requires one aerobic and one anaerobic bottle.
• Urine culture and urinalysis: Indicated when a urinary source is suspected
• Respiratory cultures (sputum, bronchoalveolar lavage): Indicated for suspected pneumonia
• Wound, catheter tip, or drain cultures: As clinically indicated
• Lumbar puncture (CSF analysis): When central nervous system infection is suspected

Markers of Infection and Inflammation

• Procalcitonin (PCT): Elevated in bacterial sepsis (typically > 0.5 ng/mL); useful for guiding antibiotic de-escalation; less specific in some viral, fungal, and non-infectious inflammatory states
• C-reactive protein (CRP): Non-specific acute phase reactant; elevated in sepsis but also in many other inflammatory conditions
• Lactate (serum or arterial): A critical marker of tissue hypoperfusion and anaerobic metabolism. Lactate > 2 mmol/L suggests sepsis-related hypoperfusion; lactate > 4 mmol/L is associated with significantly increased mortality and may indicate septic shock even in the absence of frank hypotension. Serial lactate measurements (every 2 hours) are used to assess response to resuscitation (lactate clearance ≥ 10% is a resuscitation target).
• Complete blood count (CBC) with differential: Leukocytosis (WBC > 12,000/μL) or leukopenia (< 4,000/μL); bandemia (> 10% bands = “left shift”); thrombocytopenia (platelet count < 100,000/μL) — an early indicator of sepsis-induced coagulopathy

Organ Function Assessment

• Comprehensive metabolic panel (CMP): Elevated blood urea nitrogen (BUN) and creatinine (AKI); elevated liver enzymes (AST, ALT, alkaline phosphatase, total bilirubin — hepatic dysfunction); hyponatremia, hypokalemia, or hyperkalemia
• Arterial blood gas (ABG): Metabolic acidosis (pH < 7.35, low HCO₃⁻, negative base excess) with or without respiratory compensation; hypoxemia (PaO₂ < 80 mmHg); high anion gap (> 12 mEq/L in lactic acidosis)
• Coagulation studies: Prolonged prothrombin time (PT), elevated INR, prolonged aPTT, decreased fibrinogen, elevated D-dimer — collectively consistent with sepsis-induced coagulopathy or DIC
• Troponin and BNP/NT-proBNP: Elevated in septic cardiomyopathy; troponin elevation is common in sepsis and correlates with mortality

Imaging Studies

• Chest radiograph: Identifies pneumonia, ARDS (bilateral infiltrates, air-space opacification), pleural effusion, or pulmonary edema; portable film often obtained emergently
• Bedside point-of-care ultrasound (POCUS): Increasingly used to assess cardiac function (ejection fraction, wall motion), volume responsiveness (IVC collapsibility), and pleural/abdominal fluid
• CT scan (chest, abdomen, pelvis): Identifies the infection source (e.g., abscess, perforation, cholecystitis) when not clinically apparent; requires patient stability for transport
• Ultrasound of abdomen/pelvis: Evaluates biliary, renal, or pelvic sources

Hemodynamic Monitoring

• Central venous pressure (CVP): Measured via central venous catheter; normal 2–8 mmHg; limited use as sole resuscitation endpoint (dynamic measures preferred)
• Central venous oxygen saturation (ScvO₂): Target ≥ 70%; reflects balance between oxygen delivery and demand
• Continuous cardiac output monitoring: Pulmonary artery catheter (PAC) or non-invasive devices (e.g., arterial waveform analysis) used in complex cases or persistent hemodynamic instability

---

Nursing Assessment

Subjective Data

A thorough nursing history rapidly focuses the assessment on infection risk, severity, and potential source:

• Chief complaint and duration of symptoms; onset and progression
• Recent infections, procedures, hospitalizations, or antibiotic use
• Immunosuppressive conditions or medications (diabetes, cancer chemotherapy, long-term corticosteroids, biologic agents, renal failure, HIV)
• Presence of invasive devices: central venous catheters, urinary catheters, mechanical ventilation, wounds, or surgical drains
• Travel history, animal exposures, or occupational exposures relevant to atypical pathogens
• History of substance use (intravenous drug use and endocarditis risk)
• Allergies — particularly antibiotic allergies that will direct empiric therapy selection
• Current medications, including anticoagulants and immunosuppressants
• Patient or family-reported changes: confusion, shaking chills, decreased urine output, worsening pain at a known infection site

Objective Data

A rapid, systematic head-to-toe assessment is performed with simultaneous monitoring data interpretation:

Neurological: Level of consciousness using the Glasgow Coma Scale (GCS); orientation (person, place, time, event); presence of agitation, confusion, or delirium using the Confusion Assessment Method for the ICU (CAM-ICU); pupil size and reactivity

Cardiovascular: Heart rate and rhythm; blood pressure (compare to baseline); quality of peripheral pulses; capillary refill time; skin color, temperature, and moisture; presence of petechiae, purpura, or new rash; presence of edema (peripheral, sacral)

Respiratory: Respiratory rate, depth, and effort; SpO₂ and oxygen delivery requirements; auscultation of breath sounds (crackles, diminished sounds); use of accessory muscles; presence of pursed-lip breathing

Renal/Urinary: Hourly urinary output (target ≥ 0.5 mL/kg/hr); urine color, clarity, and odor; presence of suprapubic tenderness or costovertebral angle (CVA) tenderness

Gastrointestinal: Bowel sounds in all four quadrants; abdominal palpation for tenderness, guarding, rigidity; presence of wounds, ostomies, or drains; last bowel movement

Integumentary: Inspection of all skin surfaces — especially pressure points, venous access sites, wounds, surgical incisions, and perianal area — for redness, warmth, drainage, or signs of infection; assessment of the oral mucosa

Temperature: Core temperature measurement; recognition that hypothermia is as significant as fever in sepsis assessment

Focused Exam Findings

Key sepsis-specific clinical flags that require immediate escalation:

• New or worsening hypotension or tachycardia unresponsive to initial fluid bolus
• Rapidly rising lactate or failure of lactate to clear despite resuscitation
• Deteriorating mental status or new-onset delirium
• Increasing oxygen requirement or new hypoxemia
• Urine output < 0.5 mL/kg/hr for two or more consecutive hours
• New petechiae or purpura suggesting meningococcemia or DIC
• Fever with rigors in a patient with an indwelling central venous catheter (high suspicion for catheter-associated bacteremia)

---

Nursing Interventions

Nursing interventions in sepsis are time-sensitive and grounded in the Surviving Sepsis Campaign (SSC) Hour-1 Bundle — a distilled set of evidence-based actions that must begin within the first hour of sepsis recognition.

Hour-1 Bundle Actions (Surviving Sepsis Campaign, 2018)

1. Measure a serum lactate. Repeat lactate measurement if initial lactate > 2 mmol/L; target lactate clearance ≥ 10% over 2 hours.
2. Obtain blood cultures before administering antibiotics. Draw at least 2 sets (aerobic and anaerobic bottles) from two separate peripheral sites or one peripheral and one from each lumen of an existing central catheter. Do not delay antibiotic administration beyond 45 minutes to obtain cultures.
3. Administer broad-spectrum antibiotics. Empiric antibiotics should be administered within 1 hour of sepsis recognition; the specific regimen is selected based on suspected source, local resistance patterns, and patient allergy history.
4. Administer 30 mL/kg of crystalloid IV for hypotension or lactate ≥ 4 mmol/L. Infuse rapidly (within the first 3 hours); reassess hemodynamic response after each bolus using dynamic measures (pulse pressure variation, passive leg raise, respiratory variation in IVC diameter on ultrasound).
5. Apply vasopressors if patient remains hypotensive during or after fluid resuscitation to maintain MAP ≥ 65 mmHg.

Ongoing Nursing Priorities

Hemodynamic monitoring and resuscitation:

• Monitor blood pressure, heart rate, and MAP continuously or at frequent intervals; titrate vasopressor infusions per protocol and physician/APRN orders
• Reassess clinical response to fluid resuscitation; avoid fluid overload — excess crystalloid is associated with worse outcomes
• Monitor central venous pressure, ScvO₂, and cardiac output parameters if invasive monitoring is in place
• Report failure to achieve resuscitation endpoints promptly to the provider

Infection source control:

• Assist with or coordinate procedures to remove or drain infection sources: abscess drainage, line removal and replacement, catheter changes, wound debridement, or emergent surgical consultation
• Maintain strict aseptic technique during all invasive line and catheter care to prevent secondary infection
• Implement central line bundle, urinary catheter bundle, and ventilator bundle (CLABSI/CAUTI/VAP prevention) as applicable

Respiratory support:

• Maintain SpO₂ ≥ 94% or per provider order; apply supplemental oxygen; prepare for non-invasive or invasive mechanical ventilation as condition warrants
• Elevate head of bed 30–45° to reduce aspiration risk in intubated patients
• Use lung-protective ventilation settings (low tidal volume 6 mL/kg IBW, plateau pressure ≤ 30 cmH₂O) in ARDS per protocol

Renal protection:

• Maintain MAP ≥ 65 mmHg to preserve renal perfusion pressure
• Monitor hourly urine output; report oliguria promptly
• Avoid nephrotoxic agents whenever possible; adjust renally cleared drug doses according to estimated GFR
• Prepare for renal replacement therapy (continuous renal replacement therapy [CRRT] or intermittent hemodialysis) as prescribed

Glycemic management:

• Monitor blood glucose every 1–2 hours in ICU or per protocol in non-ICU settings; hyperglycemia is common in sepsis and worsens outcomes
• Maintain blood glucose 140–180 mg/dL in critically ill patients using insulin infusion per protocol; avoid hypoglycemia (glucose < 70 mg/dL), which is independently associated with increased mortality

Prevention of secondary complications:

• Implement deep vein thrombosis (DVT) prophylaxis: pharmacological (unfractionated heparin or low-molecular-weight heparin) and mechanical (sequential compression devices) unless contraindicated
• Provide stress ulcer prophylaxis (proton pump inhibitor or H₂ blocker) in high-risk patients
• Implement early enteral nutrition within 24–48 hours when feasible and hemodynamically appropriate
• Maintain oral care every 4 hours; frequent position changes and skin assessment for pressure injury prevention

Communication and collaboration:

• Communicate changes in patient status using SBAR (Situation-Background-Assessment-Recommendation) to ensure rapid provider notification
• Participate in interprofessional rounds; advocate for goal-directed resuscitation endpoint reassessment
• Document assessment findings, interventions, and patient responses accurately and in real time — sepsis documentation directly impacts regulatory compliance and quality reporting

Psychosocial support:

• Orient the confused or delirious patient frequently; use reorientation boards, familiar voices, and minimization of sedation
• Keep family informed of patient condition and care plan; involve family in goal-of-care conversations as appropriate
• Address family anxiety with compassionate communication and education about the sepsis trajectory

---

Pharmacological Considerations

Antimicrobial Therapy

Broad-spectrum empiric antibiotic therapy is the cornerstone of sepsis pharmacological management and should be initiated within one hour of sepsis recognition. Antibiotic selection is guided by the suspected infection source, likely causative organisms, local antibiogram, patient allergy history, and recent antibiotic exposure.

Common empiric antibiotic regimens by source:

Suspected Source	Common Empiric Regimen
Unknown source / broad coverage	Piperacillin-tazobactam (Zosyn) + vancomycin
Pneumonia (community-acquired)	Ceftriaxone + azithromycin or respiratory fluoroquinolone
Pneumonia (hospital-acquired / VAP)	Piperacillin-tazobactam or cefepime + vancomycin ± antipseudomonal agent
Urinary source	Ceftriaxone or fluoroquinolone (if susceptible); carbapenem for resistant organisms
Intra-abdominal source	Piperacillin-tazobactam or meropenem ± metronidazole
Skin and soft tissue	Vancomycin + piperacillin-tazobactam
Suspected MRSA	Vancomycin or daptomycin
Suspected fungal	Micafungin, caspofungin, or fluconazole based on species and risk

Nursing implications for antimicrobial therapy:

• Verify antibiotic allergies and cross-reactivity risks before administration (e.g., penicillin-cephalosporin cross-reactivity is low but clinically relevant in documented anaphylaxis)
• Administer the first antibiotic dose as a priority “STAT” medication; document the time of administration
• Monitor for infusion reactions (vancomycin red man syndrome: flushing, erythema, and pruritus of the face, neck, and upper torso — slow the infusion rate and pre-medicate with diphenhydramine as ordered)
• Monitor vancomycin trough levels or AUC/MIC (per facility protocol) to ensure therapeutic dosing and minimize nephrotoxicity; vancomycin is synergistically nephrotoxic with aminoglycosides and contrast agents
• Support antibiotic de-escalation (narrowing of spectrum based on culture results) within 48–72 hours to reduce resistance risk — advocate for procalcitonin-guided de-escalation if available

Vasopressors

Vasopressors are indicated when MAP remains < 65 mmHg despite adequate fluid resuscitation. All vasopressors are administered through a central venous catheter whenever possible to minimize the risk of extravasation injury.

• Norepinephrine (Levophed): First-line vasopressor in septic shock. A potent alpha-1 and beta-1 adrenergic agonist that increases systemic vascular resistance and cardiac output. Titrated to achieve MAP ≥ 65 mmHg. Nursing: Monitor for digital ischemia and peripheral vasoconstriction; assess peripheral pulses and skin perfusion frequently; extravasation causes tissue necrosis — treat immediately with phentolamine.
• Vasopressin: Added as a second-line agent when norepinephrine requirements are high (typically > 0.25–0.5 mcg/kg/min); acts on V1 receptors to restore vasomotor tone. Fixed dose (typically 0.03–0.04 units/min), not titrated. Nursing: Monitor for cardiac ischemia, mesenteric ischemia, and skin blanching.
• Epinephrine: Third-line or adjunctive agent; combined alpha and beta agonist; increases MAP and heart rate. Nursing: Monitor for tachyarrhythmias and lactic acidosis (epinephrine independently elevates lactate via beta-2 stimulation — do not interpret rising lactate as resuscitation failure in patients receiving epinephrine).
• Phenylephrine: Pure alpha-1 agonist; reserved for tachyarrhythmic patients or specific circumstances; increases afterload without inotropy.
• Dopamine: No longer preferred first-line due to increased arrhythmia risk; may be used in highly selected patients with bradycardia.

Corticosteroids

Hydrocortisone (200 mg/day as continuous IV infusion or divided doses) is recommended in patients with septic shock who remain hemodynamically unstable despite adequate fluid resuscitation and vasopressor therapy. The mechanism is thought to involve restoration of vascular sensitivity to catecholamines (relative adrenal insufficiency) and blunting of the hyperinflammatory response. Evidence from the ADRENAL and APROCCHSS trials supports a reduction in vasopressor duration and a potential mortality benefit in certain populations.

Nursing implications: Monitor blood glucose closely (corticosteroids promote hyperglycemia); monitor for gastrointestinal bleeding (combine with stress ulcer prophylaxis); assess for signs of superinfection; taper corticosteroids when vasopressors are being weaned rather than abrupt discontinuation.

Other Pharmacological Agents

• Intravenous immunoglobulin (IVIG): Considered in specific high-risk populations (e.g., streptococcal toxic shock syndrome, neonatal sepsis); not routinely recommended
• Activated protein C (drotrecogin alfa): Withdrawn from the market following the PROWESS-SHOCK trial; no longer recommended
• Insulin infusion: For glycemic management in critically ill patients; target glucose 140–180 mg/dL; intensive glucose control (< 110 mg/dL) is associated with increased hypoglycemia and harm
• Sodium bicarbonate: Not routinely recommended for metabolic acidosis in sepsis; may be considered in severe metabolic acidosis (pH < 7.15) with AKI per provider order

---

Patient and Family Education

Patient and family education in sepsis encompasses three distinct phases: acute care (while the patient is hemodynamically unstable and likely unable to fully engage in learning), recovery (as cognition and stability improve), and discharge planning (preparing for the post-acute environment and preventing recurrence). Education must be tailored to the patient’s cognitive status, literacy level, cultural background, and emotional readiness.

Acute Phase Education

During the acute phase, education is primarily directed at the family and support persons:

• Explain the diagnosis of sepsis clearly: “Sepsis is a very serious condition where the body’s response to a dangerous infection begins to damage the body’s own organs.”
• Clarify that sepsis is not contagious — family members do not need to fear visiting
• Explain the purpose of each intervention (IV fluids, antibiotics, oxygen, monitoring equipment) in accessible language
• Set realistic expectations about the ICU environment, alarms, and fluctuating clinical status
• Identify a primary family spokesperson for daily updates and facilitate family-centered care through open visiting hours when possible
• Introduce the concept of the sepsis trajectory — improvement is possible but may be gradual and non-linear

Recovery and Discharge Education

As the patient regains cognitive function and stability, education shifts to individualized teaching:

• Infection prevention:

  • Meticulous hand hygiene — wash hands for at least 20 seconds with soap and water, especially before eating and after using the restroom
  • Keep all vaccinations current (influenza, pneumococcal, and COVID-19 are particularly important for sepsis survivors)
  • Wound care: keep wounds clean and covered; monitor for signs of infection (redness, warmth, swelling, increased pain, purulent drainage); report promptly
  • Recognize and seek care early for infection symptoms: fever, chills, worsening pain, increasing confusion, or rapid breathing

• Post-sepsis syndrome (PSS):

  • Many sepsis survivors experience prolonged physical, cognitive, and psychological sequelae
  • Physical effects: Muscle weakness, fatigue, reduced exercise tolerance, hair loss, reduced appetite, sleep disturbance
  • Cognitive effects: Memory difficulties, difficulty concentrating, “brain fog”
  • Psychological effects: Anxiety, depression, post-traumatic stress disorder (PTSD) — screen using validated tools at follow-up appointments
  • Reassure patients and families that recovery takes months and ongoing support is available

• Follow-up care:

  • Emphasize the importance of attending all scheduled follow-up appointments with primary care, nephrology (if AKI occurred), pulmonology (if ARDS), or other specialists
  • Provide written medication instructions, including name, purpose, dose, schedule, and potential side effects of each discharge medication
  • Review signs and symptoms requiring emergency re-evaluation: high fever, new confusion, difficulty breathing, decreased urine output, or inability to take oral medications

• Mental health resources:

  • Connect patients and families with social work, case management, sepsis support groups (e.g., Sepsis Alliance), and community mental health services as appropriate

---

Complications and Nursing Implications

Sepsis is associated with a broad spectrum of potentially life-threatening complications that may develop acutely during the hospitalization or emerge during the recovery phase. Nursing vigilance is central to early complication detection and the initiation of timely interventions.

Acute Respiratory Distress Syndrome (ARDS)

ARDS develops in approximately 20–40% of patients with sepsis and is characterized by bilateral pulmonary infiltrates, severe hypoxemia (PaO₂/FiO₂ ratio < 300), and non-cardiogenic pulmonary edema. It is the most common organ failure associated with sepsis. Nursing implications: Maintain lung-protective ventilation settings (tidal volume 6 mL/kg ideal body weight; plateau pressure ≤ 30 cmH₂O); implement prone positioning as ordered for severe ARDS (PaO₂/FiO₂ < 150); monitor for ventilator-associated pneumonia (VAP); provide meticulous ventilator bundle care; manage sedation carefully.

Acute Kidney Injury (AKI)

AKI occurs in 40–50% of patients with septic shock and significantly worsens prognosis. It results from renal hypoperfusion, endothelial injury, inflammatory mediator exposure, and nephrotoxic medication exposure. Nursing implications: Maintain MAP ≥ 65 mmHg; monitor urine output hourly; trend serum creatinine and BUN; avoid nephrotoxic agents (aminoglycosides, NSAIDs, IV contrast without nephroprotective measures); collaborate with nephrology for renal replacement therapy decisions; educate patients on long-term kidney disease risk.

Disseminated Intravascular Coagulation (DIC)

DIC is a catastrophic coagulopathy characterized by simultaneous systemic thrombosis and hemorrhage, resulting from consumption of clotting factors and platelets. It occurs in up to 35% of septic shock patients. Nursing implications: Monitor platelet count, PT/INR, aPTT, fibrinogen, and D-dimer; assess for bleeding (petechiae, purpura, oozing from IV sites, hematuria, melena) and thrombosis (extremity swelling, pallor, pulselessness); minimize venipunctures; apply prolonged pressure after procedures; administer fresh frozen plasma, cryoprecipitate, or platelet transfusions per protocol; treat the underlying sepsis as the primary intervention.

Septic Cardiomyopathy

Biventricular dysfunction complicates up to 44% of septic shock patients and is characterized by reduced ejection fraction, ventricular dilation, and impaired contractility — paradoxically accompanied by preserved cardiac output in the hyperdynamic early phase. Cardiomyopathy is generally reversible with sepsis treatment. Nursing implications: Monitor for dysrhythmias; assess for worsening hemodynamic instability despite vasopressors; collaborate with cardiology; prepare for echocardiography; titrate vasopressors and inotropes carefully.

Sepsis-Associated Encephalopathy (SAE)

SAE is the most common cause of altered consciousness in ICU patients, occurring in up to 70% of sepsis patients. It ranges from subtle inattention to deep coma and is associated with long-term cognitive impairment. Nursing implications: Assess GCS and CAM-ICU at every nursing shift; minimize sedation (ABCDEF bundle — Awakening, Breathing, Coordination, Delirium screening, Early mobility, Family engagement); reorient frequently; maintain sleep-wake cycles; facilitate early mobility as tolerated; monitor for and treat delirium aggressively.

Post-Sepsis Syndrome (PSS)

PSS encompasses the spectrum of physical, cognitive, and psychological deficits that persist after ICU discharge. Physical deficits include ICU-acquired weakness (ICUAW), neuropathy, and fatigue; cognitive deficits include memory impairment and executive dysfunction; psychological sequelae include depression, anxiety, and PTSD in up to 30–50% of survivors. Nursing implications: Screen for PTSD and depression at discharge and follow-up using validated tools (PCL-5, PHQ-9); initiate early physical and occupational therapy referrals; connect patients with sepsis survivor resources; communicate PSS risk to outpatient care team.

Healthcare-Associated Infections (HAIs)

The immunosuppressed phase of sepsis dramatically increases vulnerability to secondary infections, including central line–associated bloodstream infections (CLABSI), catheter-associated urinary tract infections (CAUTI), ventilator-associated pneumonia (VAP), and Clostridioides difficile colitis (from broad-spectrum antibiotic use). Nursing implications: Apply all relevant prevention bundles; reassess the ongoing need for invasive devices daily and remove promptly when no longer indicated; practice meticulous hand hygiene; monitor for clinical signs of new or worsening infection.

---

Special Populations / Lifespan Considerations

Older Adults (≥ 65 years)

Older adults are disproportionately affected by sepsis, accounting for the majority of sepsis hospitalizations. Age-related physiological changes — including immunosenescence, reduced cardiac reserve, baseline cognitive impairment, polypharmacy, malnutrition, and impaired renal function — dramatically alter the presentation, trajectory, and management of sepsis in this population.

Clinically, older adults may not manifest fever due to blunted thermoregulatory responses; tachycardia may be attenuated by chronotropic incompetence or beta-blocker use; and altered mental status or delirium may be the first or only sign of sepsis. The absence of classic sepsis criteria does not rule out the diagnosis.

Fluid resuscitation in older adults requires careful titration: the reduced cardiovascular reserve increases risk of fluid overload and pulmonary edema. Vasopressors may be needed earlier. Cognitive decline after sepsis is particularly pronounced and often permanent in older adults — this should be communicated to families during and after the hospitalization.

Pediatric Patients

Pediatric sepsis is defined using age-specific vital sign thresholds and diagnostic criteria (Sepsis-3 pediatric definitions, 2024). Children are more likely to present with tachycardia as the predominant early sign, may maintain normal blood pressure until late decompensation (due to physiological compensatory mechanisms), and are at particular risk for certain pathogens (e.g., Group B Streptococcus in neonates; Neisseria meningitidis in toddlers and adolescents). Neonatal sepsis (age < 28 days) carries the highest mortality risk of all age groups. Fluid and medication dosing is weight-based.

Immunocompromised Patients

Patients with HIV/AIDS, solid organ transplant, hematological malignancies, or those receiving immunosuppressive therapy are at markedly elevated risk for sepsis from opportunistic pathogens (e.g., Pneumocystis jirovecii, Candida, Aspergillus, Cryptococcus, cytomegalovirus). Empiric antibiotic regimens must be broadened accordingly, and the threshold for antifungal coverage should be lowered. In neutropenic sepsis (absolute neutrophil count < 500/μL), immediate initiation of antipseudomonal antibiotics without delay for cultures is the standard of care.

Pregnant Patients

Sepsis in pregnancy (obstetric sepsis) represents a leading cause of maternal mortality worldwide. The most common sources include urinary tract infection, chorioamnionitis, endometritis, and wound infection. Physiological adaptations of pregnancy — including baseline tachycardia, hypotension, leukocytosis, and elevated respiratory rate — make early recognition challenging. Standard sepsis criteria must be interpreted against gestational-age–specific norms. Fetal status must be continuously monitored; treatment decisions may involve the obstetric team, neonatology, and maternal-fetal medicine. Delivery may be required as part of infection source control. Certain medications (e.g., fluoroquinolones, tetracyclines, aminoglycosides at high doses) require careful risk-benefit analysis in pregnancy.

Patients with Chronic Illness

Patients with diabetes mellitus, chronic kidney disease, chronic liver disease, or cardiovascular disease have increased baseline vulnerability to sepsis and more complex resuscitation needs. For example:

• Diabetes: Baseline immune dysfunction, neuropathy masking pain, hyperglycemia worsening outcomes
• CKD: Altered drug clearance, fluid management complexity, reduced bicarbonate buffer capacity
• Cirrhosis: Coagulopathy at baseline, risk for spontaneous bacterial peritonitis (SBP) as a sepsis source, reduced ability to synthesize clotting factors and albumin
• Heart failure: Reduced tolerance for fluid resuscitation, need for earlier vasopressor initiation

---

Evidence Base and Clinical Guidelines

Sepsis management is supported by a robust and evolving evidence base synthesized by international expert bodies. The following guidelines and landmark trials form the foundation of contemporary nursing and medical practice:

Key Clinical Guidelines

• Surviving Sepsis Campaign (SSC) International Guidelines for Management of Sepsis and Septic Shock (2021): The most comprehensive and widely adopted clinical practice guideline, updated collaboratively by the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM). Encompasses all aspects of sepsis management including resuscitation bundles, antimicrobial therapy, vasopressors, ventilation, and long-term recovery. Available at survivingsepsis.org.
• Sepsis-3 Consensus Definitions (Singer et al., JAMA, 2016): Redefined sepsis as life-threatening organ dysfunction caused by a dysregulated host response to infection; introduced the SOFA and qSOFA scoring tools; replaced the SIRS-based criteria.
• Hour-1 Bundle (Surviving Sepsis Campaign, 2018): Distilled the key resuscitation elements into five time-sensitive actions to be initiated within the first hour of sepsis recognition.
• NICE Guideline NG51: Sepsis (National Institute for Health and Care Excellence, 2016, updated 2024): UK-based national guideline emphasizing risk stratification, the sepsis screening tool, and escalation protocols.

Landmark Clinical Trials

• ProCESS, ARISE, and ProMISe Trials (2014–2015): Three landmark RCTs demonstrating that early goal-directed therapy (EGDT) as originally defined by Rivers et al. was not superior to usual care in terms of 90-day mortality, leading to a more flexible, patient-tailored approach to resuscitation targets.
• ADRENAL Trial (Venkatesh et al., NEJM, 2018): Demonstrated that hydrocortisone in septic shock reduced vasopressor duration and time to ICU discharge without improving 90-day mortality.
• APROCCHSS Trial (Annane et al., NEJM, 2018): Found that hydrocortisone plus fludrocortisone reduced 90-day mortality in septic shock patients.
• SMART Trial (Semler et al., NEJM, 2018): Demonstrated that balanced crystalloids (lactated Ringer’s solution or Plasma-Lyte) were associated with lower rates of major adverse kidney events compared to normal saline for ICU resuscitation.
• PRISM and SALT-ED Trials (2018): Supported the use of balanced crystalloids over normal saline in non-critically ill patients as well.
• ANDROMEDA-SHOCK Trial (Hernandez et al., JAMA, 2019): Demonstrated that capillary refill time–guided resuscitation was associated with lower organ dysfunction scores compared to lactate-guided resuscitation, suggesting complementary roles for both endpoints.

Relevant Professional Organizations and Resources

• Society of Critical Care Medicine (SCCM): sccm.org — Surviving Sepsis Campaign, ICU Liberation Collaborative (ABCDEF Bundle)
• Sepsis Alliance: sepsis.org — Patient and public education, survivor support, T.I.M.E. recognition campaign
• National Sepsis Alliance / Institute for Healthcare Improvement (IHI): Sepsis quality improvement initiatives and measurement tools
• Centers for Disease Control and Prevention (CDC): cdc.gov/sepsis — Epidemiology data, hospital sepsis program resources, antibiotic stewardship

---

NCLEX-NG Formative Check Questions

The following questions are written in Next Generation NCLEX (NGN) format and are designed to assess clinical judgment at the analysis and application levels of Bloom’s taxonomy. They align with the NCLEX-NG Clinical Judgment Measurement Model (CJMM), specifically targeting the cognitive skills of Recognize Cues, Analyze Cues, Prioritize Hypotheses, Generate Solutions, and Take Action.

---

Question 1 — Extended Multiple Response (Select All That Apply)

Clinical scenario: A nurse is caring for a 68-year-old male patient admitted from a long-term care facility with a 2-day history of productive cough, decreased oral intake, and increasing confusion. His family reports he has been “not himself” for 48 hours. Current vital signs: T 38.9°C (102°F), HR 118 bpm, RR 24 breaths/min, BP 94/58 mmHg, SpO₂ 91% on room air. Serum lactate is 3.4 mmol/L. He opens his eyes to voice but is disoriented to place and time (GCS 12).

Question: Which of the following nursing actions are the highest priority at this time? Select all that apply.

• A. Administer acetaminophen 650 mg PO for fever management
• B. Draw two sets of blood cultures from two separate sites
• C. Obtain a 12-lead electrocardiogram
• D. Initiate intravenous access and prepare for a 30 mL/kg crystalloid fluid bolus
• E. Notify the provider and request urgent sepsis protocol activation
• F. Administer prescribed broad-spectrum IV antibiotics as soon as possible
• G. Place the patient in a prone position
• H. Measure urine output hourly via indwelling urinary catheter

Correct answers: B, D, E, F, H

Rationale: This patient meets criteria for sepsis (suspected infection + acute organ dysfunction: hypotension, tachycardia, tachypnea, altered mental status, elevated lactate, hypoxemia) and should be managed urgently with the SSC Hour-1 Bundle. Blood cultures (B) must be drawn before antibiotics. IV fluid resuscitation at 30 mL/kg (D) is indicated for hypotension and lactate ≥ 2 mmol/L. Provider notification and sepsis protocol activation (E) ensures timely escalation. Broad-spectrum antibiotics (F) should be administered within 1 hour. Hourly urine output monitoring (H) assesses renal perfusion response to resuscitation. Acetaminophen (A) is not an immediate priority over resuscitation. ECG (C) is not the highest priority at this time. Prone positioning (G) is indicated for severe ARDS, not at initial sepsis presentation.

---

Question 2 — Matrix/Grid (Multiple Choice Per Row)

Clinical scenario: A nurse is reassessing a 52-year-old female patient with septic shock secondary to a ruptured appendix. She is receiving norepinephrine at 0.18 mcg/kg/min and has completed 3 L of lactated Ringer’s solution. Current vital signs: T 37.2°C, HR 108 bpm, RR 22 breaths/min, MAP 61 mmHg, SpO₂ 94% on 4 L/min nasal cannula, urine output 18 mL over the past hour (weight 60 kg), serum lactate 4.1 mmol/L (2 hours ago: 4.8 mmol/L).

Question: For each assessment finding below, indicate whether the finding suggests the patient is Responding to treatment, Not responding to treatment, or is Not enough information to determine.

Finding	Responding	Not Responding	Not Enough Information
MAP 61 mmHg on norepinephrine 0.18 mcg/kg/min		✓
Lactate decrease from 4.8 to 4.1 mmol/L over 2 hours		✓
SpO₂ 94% on 4 L/min nasal cannula	✓
Urine output 18 mL/hr (0.3 mL/kg/hr)		✓
Temperature 37.2°C	✓

Rationale: MAP < 65 mmHg despite norepinephrine indicates hemodynamic instability — not responding. Lactate decreased only 14.6% from 4.8 to 4.1 (target is ≥ 10% clearance; technically met, but lactate remains severely elevated at > 4 mmol/L and the patient has persistent MAP deficiency — clinical judgment is that resuscitation is inadequate). SpO₂ ≥ 94% on low-flow oxygen is an acceptable response. Urine output of 0.3 mL/kg/hr is below the target of 0.5 mL/kg/hr, indicating persistent renal hypoperfusion — not responding. Temperature normalization suggests the systemic inflammatory response may be partially controlled.

---

Question 3 — Drop-Down Cloze (Fill in the blank)

Clinical scenario: The nurse is administering vancomycin to a patient with sepsis when the patient develops flushing of the face, neck, and upper chest, as well as pruritus and erythema, approximately 15 minutes into the infusion.

Question: The nurse recognizes this reaction as ____ and the priority nursing action is to ____.

Option set for blank 1: Anaphylaxis / Red man syndrome / Serum sickness / Contact dermatitis
Option set for blank 2: Immediately stop the infusion and administer epinephrine IM / Slow the infusion rate and administer diphenhydramine as ordered / Discontinue vancomycin and switch to an alternative antibiotic / Apply topical corticosteroid cream to affected areas

Correct answers: Red man syndrome; Slow the infusion rate and administer diphenhydramine as ordered

Rationale: Red man syndrome is a non-immunological infusion-related reaction to vancomycin caused by direct mast cell degranulation. It is characterized by flushing, erythema, and pruritus of the face, neck, and upper torso — typically occurring within the first 30 minutes of infusion. Unlike anaphylaxis, it does not involve IgE-mediated hypersensitivity and does not require epinephrine. The first-line management is to slow or temporarily pause the infusion and administer diphenhydramine (Benadryl) as ordered; the infusion can typically be restarted at a slower rate. Anaphylaxis would present with bronchospasm, urticaria, and cardiovascular collapse requiring epinephrine.

---

Question 4 — Trend Analysis (Highlight the Abnormal)

Clinical scenario: A nurse reviews the following laboratory trend for a patient with septic shock on day 2 of hospitalization. The patient is currently receiving vancomycin and piperacillin-tazobactam.

Lab Value	Day 0 (Admission)	Day 1	Day 2
WBC (×10³/μL)	18.4	14.2	9.8
Platelets (×10³/μL)	182	124	71
Creatinine (mg/dL)	1.1	1.8	2.9
Lactate (mmol/L)	4.2	2.8	1.6
INR	1.2	1.5	2.1

Question: Which laboratory trends are most concerning and indicate worsening organ dysfunction? Select all that apply.

• A. Decreasing WBC from 18.4 to 9.8
• B. Decreasing platelet count from 182 to 71
• C. Rising creatinine from 1.1 to 2.9 mg/dL
• D. Decreasing lactate from 4.2 to 1.6 mmol/L
• E. Rising INR from 1.2 to 2.1

Correct answers: B, C, E

Rationale: A declining platelet count (B) is a hallmark of sepsis-induced thrombocytopenia and may herald DIC — a platelet count below 100 is significant. A rising creatinine (C) from 1.1 to 2.9 mg/dL over 2 days meets KDIGO Stage 2 AKI criteria and indicates progressive renal failure. A rising INR (E) from 1.2 to 2.1 signals worsening coagulopathy, consistent with developing DIC. A decreasing WBC (A) from leukocytosis toward normal is a favorable sign of resolving infection or immune activation; leukopenia would be concerning, but a count of 9.8 is within normal limits. A decreasing lactate (D) from 4.2 to 1.6 mmol/L indicates improving tissue perfusion — a favorable response to resuscitation.